Research

The science behind
smarter trials

Our research teams publish on innovative AI methods and advanced disease modeling to support clinical development across therapeutic areas.

Alzheimer’s disease
Amyotrophic Lateral Sclerosis
Asthma
Atopic Dermatitis
COPD
Coronary Artery Disease
Crohn’s disease
Dyslipidemia
Frontotemporal dementia
Huntington's disease
Hypertension
Migraine
Obesity
Osteoarthritis
Osteoporosis
Parkinson's disease
Psoriasis
Psoriatic Arthritis
Rheumatoid Arthritis
SCI
Stroke
Type 2 Diabetes
Ulcerative Colitis
Alzheimer’s disease
Amyotrophic Lateral Sclerosis
Asthma
Atopic Dermatitis
COPD
Coronary Artery Disease
Crohn’s disease
Dyslipidemia
Frontotemporal dementia
Huntington's disease
Hypertension
Migraine
Obesity
Osteoarthritis
Osteoporosis
Parkinson's disease
Psoriasis
Psoriatic Arthritis
Rheumatoid Arthritis
SCI
Stroke
Type 2 Diabetes
Ulcerative Colitis

Publications

Learn why leading biopharma sponsors trust our AI-powered products and solutions in their most important clinical programs.

Our perspectives

Decision Debt: The Cost Clinical Development Doesn't Track
How SOLA Biosciences chose to design SOL-257 with digital twins from the start
ProJenX's PRO-101 and the case for digital twins in single-arm ALS
Sign in